DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for South Korea Patent: 20160005134
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for South Korea Patent: KR20160005134
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2039-02-26 | asparaginase | Merck | ELSPAR |
Start Trial | 2029-11-24 | abciximab | Centocor Inc | REOPRO |
Start Trial | 2028-11-25 | rituximab | Genentech | RITUXAN |
Start Trial | 2028-11-25 | rituximab | Genentech | RITUXAN |
Start Trial | 2028-11-25 | infliximab | Centocor Inc | REMICADE |
Start Trial | 2028-11-25 | infliximab | Centocor Inc | REMICADE |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |